EKF Diagnostics Holdings plc provided earnings guidance for the full year ending December 31, 2014. For the period, the company's financial results are expected to be below consensus expectations. The company expects that unaudited revenues will show at least an increase of 24% on the previous year to £39.5 million.

Unaudited adjusted EBITDA is expected to be at least 29% up on the previous year at £6.2 million. Excluding the effect of exchange rates, revenue would have been expected to be up at least 30% year on year and adjusted EBITDA would have been expected to be up at least 37%.